U.S. market Closed. Opens in 11 hours 59 minutes

MGTA | Magenta Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
RevenueN/AN/AN/AN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/AN/AN/AN/A
Gross ProfitN/AN/AN/AN/AN/AN/AN/A
Operating Expenses80.90M74.69M78.70M82.97M59.96M35.73MN/A
Selling, General & Admin25.76M27.93M28.09M23.76M18.62M7.83M3.49M
Research & Development55.14M46.77M50.62M59.21M41.34M27.90M5.78M
Other Operating ExpensesN/AN/AN/AN/AN/AN/AN/A
Operating Income-80.90M-74.69M-78.70M-82.97M-59.96M-35.73M-9.27M
Other Expenses / Income4.44M3.56M3.77M6.20M2.45M236.00K-163.00K
Before Tax Income-76.46M-71.14M-74.94M-76.77M-57.52M-35.49M-9.43M
Income Tax Expenses-4.44M-5.58M-5.74M-8.04M2.45MN/AN/A
Net Income-72.02M-65.56M-69.19M-68.73M-57.52M-35.49M-9.43M
Interest Expenses-4.44MN/AN/AN/AN/AN/A163.00K
Basic Shares Outstanding3.12M2.89M2.31M1.95M967.87K17.14M21.50M
Diluted Shares Outstanding3.12M2.89M2.31M1.95M967.87K17.14M21.50M
EBITDA-78.98M-74.69M-78.70M-82.97M-59.96M-35.12M-9.26M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-80.90M-71.14M-74.94M-76.77M-55.07M-35.49M-9.27M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙